hydrocortisone 10 MG/ML / salicylic acid 30 MG/ML / sulfur 30 MG/ML Topical Cream

RxCUI
1738574
RxNorm name
hydrocortisone 10 MG/ML / salicylic acid 30 MG/ML / sulfur 30 MG/ML Topical Cream
Term type
SCD
Status
Active
Updated
2026-10-22 06:59:32

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032016
Active start
032016
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
sulfur30 MG / 1 MLsulfursulfur
hydrocortisone10 MG / 1 MLhydrocortisonehydrocortisone
salicylic acid30 MG / 1 MLsalicylic acidsalicylic acid

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Cream316982

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
sulfur10223
hydrocortisone5492
salicylic acid9525

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
69683-202-1169683-202DERMOSCRIBE SEBORRHEIC DERMATITIS SULFUR, SALICYLIC ACID, HYDROCORTISONEDERMOSCRIBE PTY LTDM032

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M03269683-202DERMOSCRIBE SEBORRHEIC DERMATITIS SULFUR, SALICYLIC ACID, HYDROCORTISONEOTC MONOGRAPH DRUGDERMOSCRIBE PTY LTD

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
69683020211rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DERMOSCRIBE SEBORRHEIC DERMATITISSULFUR, SALICYLIC ACID, HYDROCORTISONEDERMOSCRIBE PTY LTD2b6bf90b-5d42-4c08-afee-56e13122285e2025-10-17WarningsExact identifier
ndc (package): 69683-202-11
ndc (product): 69683-202
ndc11 (package): 69683020211
rxcui: 1738574

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2b6bf90b-5d42-4c08-afee-56e13122285ehydrocortisone 1 % / salicylic acid 3 % / sulfur 3 % Topical Cream [PSN] · hydrocortisone 10 MG/ML / salicylic acid 30 MG/ML / sulfur 30 MG/ML Topical Cream [SCD] · hydrocortisone 1 % / salicylic acid 3 % / sulfur 3 % Topical Cream [SY]39DERMOSCRIBE (as PLD) - SEBORRHEIC DERMATITIS CREAM (69683-202)20251017

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
2b6bf90b-5d42-4c08-afee-56e13122285eDERMOSCRIBE (as PLD) - SEBORRHEIC DERMATITIS CREAM (69683-202)DERMOSCRIBE PTY LTD20251017
2b6bf90b-5d42-4c08-afee-56e13122285eDERMOSCRIBE (as PLD) - SEBORRHEIC DERMATITIS CREAM (69683-202)DERMOSCRIBE PTY LTD20241014

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01BCAntiinflammatory agents, non-steroidsATC1-4salicylic acid
ATCS02BACorticosteroidsATC1-4hydrocortisone
ATCC05AACorticosteroidsATC1-4hydrocortisone
ATCA07EACorticosteroids acting locallyATC1-4hydrocortisone
ATCA01ACCorticosteroids for local oral treatmentATC1-4hydrocortisone
ATCS01BACorticosteroids, plainATC1-4hydrocortisone
ATCD07AACorticosteroids, weak (group I)ATC1-4hydrocortisone
ATCD07XACorticosteroids, weak, other combinationsATC1-4hydrocortisone
ATCS01CBCorticosteroids/antiinfectives/mydriatics in combinationATC1-4hydrocortisone
ATCH02ABGlucocorticoidsATC1-4hydrocortisone
ATCD01AEOther antifungals for topical useATC1-4salicylic acid
ATCD10ABPreparations containing sulfurATC1-4sulfur
FDASPLN0000175576CorticosteroidEPChas_epchydrocortisone
MEDRTD006854HydrocortisoneCHEMhas_ingredienthydrocortisone
MEDRTD020156Salicylic AcidCHEMhas_ingredientsalicylic acid
MEDRTD013455SulfurCHEMhas_ingredientsulfur
MEDRTD000152Acne VulgarisDISEASEmay_treatsalicylic acid
MEDRTD000152Acne VulgarisDISEASEmay_treatsulfur
MEDRTD000312Adrenal Hyperplasia, CongenitalDISEASEmay_treathydrocortisone
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treathydrocortisone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treathydrocortisone
MEDRTD003877Dermatitis, ContactDISEASEmay_treathydrocortisone
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatsulfur
MEDRTD003881DermatomycosesDISEASEci_withhydrocortisone
MEDRTD004342Drug HypersensitivityDISEASEci_withsalicylic acid
MEDRTD004342Drug HypersensitivityDISEASEci_withsulfur
MEDRTD004342Drug HypersensitivityDISEASEci_withhydrocortisone
MEDRTD005148Facial DermatosesDISEASEmay_treathydrocortisone
MEDRTD005533Foot DermatosesDISEASEmay_treathydrocortisone
MEDRTD006229Hand DermatosesDISEASEmay_treathydrocortisone
MEDRTD006484HemorrhoidsDISEASEmay_treathydrocortisone
MEDRTD007249InflammationDISEASEmay_treathydrocortisone
MEDRTD017492Keratosis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD007868Leg DermatosesDISEASEmay_treathydrocortisone
MEDRTD011538Pruritus AniDISEASEmay_treathydrocortisone
MEDRTD011565PsoriasisDISEASEmay_treatsalicylic acid
MEDRTD011565PsoriasisDISEASEmay_treatsulfur
MEDRTD012216Rheumatic DiseasesDISEASEmay_treathydrocortisone
MEDRTD012393RosaceaDISEASEmay_treatsulfur
MEDRTD012536Scalp DermatosesDISEASEmay_treathydrocortisone
MEDRTD012536Scalp DermatosesDISEASEmay_treatsalicylic acid
MEDRTD012769ShockDISEASEmay_treathydrocortisone
MEDRTD012876Skin Diseases, ParasiticDISEASEci_withhydrocortisone
MEDRTD017193Skin Diseases, ViralDISEASEci_withhydrocortisone
MEDRTD013224Status AsthmaticusDISEASEmay_treathydrocortisone
MEDRTD014382Tuberculosis, CutaneousDISEASEci_withhydrocortisone
MEDRTD014860WartsDISEASEmay_treatsalicylic acid
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moahydrocortisone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moahydrocortisone
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moasalicylic acid
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pehydrocortisone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pehydrocortisone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pehydrocortisone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pehydrocortisone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pehydrocortisone
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pehydrocortisone
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pehydrocortisone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pehydrocortisone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pehydrocortisone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pehydrocortisone
MEDRTN0000009974Increased Skin KeratinizationPEhas_pesalicylic acid
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pehydrocortisone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH10 MG/ML / 30 MG/ML / 30 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymhydrocortisone 1 % / salicylic acid 3 % / sulfur 3 % Topical Cream
SOURCESSourceMetathesaurus FDA Structured Product Labels